IND Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System: Guidance for Industry and FDA Staff

https://www.fda.gov/media/89441/download

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top